Central vasopressin: dendritic and axonal secretion and renal actions

por Bichet, Daniel G.
Publicado 2014

A need for a systematic genetic evaluation of hereditary polyuric patients

por Bichet, Daniel G., Rice, Lawrence, Levallois-Gignac, Jasmin
Publicado 2016

Transient nephrogenic syndrome of inappropriate antidiuresis

por Kettritz, Ralph, Bichet, Daniel G., Luft, Friedrich C.
Publicado 2013

Hereditary nephrogenic diabetes insipidus: a major conundrum during labour and delivery

por Castillo, Eliana, Magee, Laura A., Bichet, Daniel, Halperin, Mitchell
Publicado 2009

A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidus

por Kobayashi, Daisuke, Nagaraj, Shashi K., Lin, Jen-Jar, Bichet, Daniel G.
Publicado 2010

The migalastat GLP-HEK assay is the gold standard for determining amenability in patients with Fabry disease

por Schiffmann, Raphael, Bichet, Daniel G., Benjamin, Elfrida, Wu, Xiaoyang, Giugliani, Roberto
Publicado 2019

A novel disease-causing mutation in AVPR2: Q96H

por Lemaire, Mathieu, Chitayat, David, Geary, Denis F., Bichet, Daniel G., Licht, Christoph
Publicado 2009

Functional Recovery of AQP2 Recessive Mutations Through Hetero-Oligomerization with Wild-Type Counterpart

por El Tarazi, Abdulah, Lussier, Yoann, Da Cal, Sandra, Bissonnette, Pierre, Bichet, Daniel G.
Publicado 2016

Vasopressin Use in the Support of Organ Donors: Physiological Rationale and Review of the Literature

por Ouerd, Sofiane, Frenette, Anne Julie, Williamson, David, Serri, Karim, D’Aragon, Frederick, Bichet, Daniel G., Charbonney, Emmanuel
Publicado 2023

Mass Spectrometry Analysis of Globotriaosylsphingosine and Its Analogues in Dried Blood Spots

por Boutin, Michel, Lavoie, Pamela, Beaudon, Margot, Kabala Ntumba, Georges, Bichet, Daniel G., Maranda, Bruno, Auray-Blais, Christiane
Publicado 2023

The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process

por Khan, Aneal, Sirrs, Sandra M., Bichet, Daniel G., Morel, Chantal F., Tocoian, Adina, Lan, Lan, West, Michael L.
Publicado 2021

Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor

por Nejsum, Lene N., Christensen, Tomas M., Robben, Joris H., Milligan, Graeme, Deen, Peter M. T., Bichet, Daniel G., Levin, Klaus
Publicado 2011

Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus—update and epidemiology

por Bichet, Daniel G., El Tarazi, Abdulah, Matar, Jessica, Lussier, Yoann, Arthus, Marie-Françoise, Lonergan, Michèle, Bockenhauer, Detlef, Bissonnette, Pierre
Publicado 2012

Disease-linked mutations alter the stoichiometries of HCN-KCNE2 complexes

por Lussier, Yoann, Fürst, Oliver, Fortea, Eva, Leclerc, Marc, Priolo, Dimitri, Moeller, Lena, Bichet, Daniel G., Blunck, Rikard, D’Avanzo, Nazzareno
Publicado 2019

Correction: Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

por Bichet, Daniel G., Aerts, Johannes M., Auray-Blais, Christiane, Maruyama, Hiroki, Mehta, Atul B., Skuban, Nina, Krusinska, Eva, Schiffmann, Raphael
Publicado 2020

Assessment of plasma lyso-Gb(3) for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease

por Bichet, Daniel G., Aerts, Johannes M., Auray-Blais, Christiane, Maruyama, Hiroki, Mehta, Atul B., Skuban, Nina, Krusinska, Eva, Schiffmann, Raphael
Publicado 2020

Long-term outcome in inherited nephrogenic diabetes insipidus

por Sharma, Sonia, Ashton, Emma, Iancu, Daniela, Arthus, Marie-Francoise, Hayes, Wesley, van’t Hoff, William, Kleta, Robert, Bichet, Daniel G, Bockenhauer, Detlef
Publicado 2018

Long-term outcome in inherited nephrogenic diabetes insipidus

por Sharma, Sonia, Ashton, Emma, Iancu, Daniela, Arthus, Marie-Francoise, Hayes, Wesley, van’t Hoff, William, Kleta, Robert, Bichet, Daniel G, Bockenhauer, Detlef
Publicado 2020

Long-term follow-up of renal function in patients treated with migalastat for Fabry disease

por Bichet, Daniel G., Torra, Roser, Wallace, Eric, Hughes, Derralynn, Giugliani, Roberto, Skuban, Nina, Krusinska, Eva, Feldt-Rasmussen, Ulla, Schiffmann, Raphael, Nicholls, Kathy
Publicado 2021

Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus

por Soroka, Steven, Alam, Ahsan, Bevilacqua, Micheli, Girard, Louis-Philippe, Komenda, Paul, Loertscher, Rolf, McFarlane, Philip, Pandeya, Sanjaya, Tam, Paul, Bichet, Daniel G.
Publicado 2017